Functional association of the N‐terminal residues with the central region in glucagon‐related peptides
Citations Over TimeTop 18% of 2011 papers
Abstract
GLP-1 is an incretin peptide involved in the regulation of glucose metabolism and the glucose-dependent stimulation of insulin secretion. Ex-4 is a paralog of GLP-1 that has comparable GLP-1R potency but extended physiological action. GLP-1 and Ex-4 are helical peptides that share ∼50% sequence homology but differ at several residues, notably the second amino acid which controls susceptibility to DPP-IV cleavage. This single amino acid difference yields divergent receptor potency when studied in the context of the two hormone sequences. Ex-4 uniquely tolerates Gly2 through select amino acid differences in the middle region of the peptide that are absent in GLP-1. We report that substitution of Ex-4 amino acids Glu16, Leu21, and Glu24 to the GLP-1 sequence enabled Gly2 tolerance. The coordination of the N-terminus with these central residues shows an interaction of substantial importance not only to DPP-IV stability but also to receptor activation. Extension of this observation to glucagon-based co-agonist peptides showed different structural requirements for effective communication between the N-terminus and the mid-section of these peptides in achieving high potency agonism at the GLP-1 and GCGRs.
Related Papers
- → Measurement of the incretin hormones: glucagon-like peptide-1 and glucose-dependent insulinotropic peptide(2014)80 cited
- → The impact of dipeptidyl peptidase 4 inhibition on incretin effect, glucose tolerance, and gastrointestinal-mediated glucose disposal in healthy subjects(2014)30 cited
- → Glucagon-like peptide-1 (GCG; GLP-1); GLP-1 receptor (GLP1R; GLP-1R)(2009)1 cited
- → Glucagon-like peptide-1 (GLP-1): a piece of the incretin puzzle.(1995)14 cited
- → Progress in the studies on extra-islet effects of incretin(2011)